Screener
Pfizer PFE EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Pfizer’s reported figures.
The source filing: Pfizer’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 7:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000078003-26-000054
FAQ
- What is Pfizer's EBITDA?
- Pfizer (PFE) reported EBITDA of $4.78B in Q1 2026.
- How has Pfizer's EBITDA changed year-over-year?
- Pfizer's EBITDA increased by 8.6% year-over-year, from $4.4B to $4.78B.
- What is the long-term trend for Pfizer's EBITDA?
- Over 2 years (2021 to 2024), Pfizer's EBITDA has grown at a -27.9% compound annual growth rate (CAGR), from $30.48B to $15.84B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Pfizer's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude